HDAC 6 inhibitor-based methods for treating cancer

• 收藏
• 分享

专利权人:

MEMORIAL SLOAN-KETTERING CANCER CENTER

发明人:

Marks, Paul A.,Namdar, Mandana,Xu, Weisheng

申请号：

AU2010270734

公开号：

AU2010270734B2

申请日:

2010.07.02

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/